China National Medicines Corporation Ltd. (SHA:600511)
China · Delayed Price · Currency is CNY 27.19
-0.75 (-2.68%)
Jun 18, 2026, 3:00 PM CST
SHA:600511 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:600511 stock has a consensus rating of "Strong Buy" and an average price target of ¥36.43. The average 1-year stock price forecast is 33.98% higher than the current stock price, while the lowest is ¥34.86 (+28.21%) and the highest is ¥38.00 (+39.76%).
Price Target: ¥36.43 (+33.98%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:600511 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Aug '25 | Sep '25 | Oct '25 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Financial Forecast
Revenue This Year
55.20B
from 52.47B
Increased by 5.21%
Revenue Next Year
57.99B
from 55.20B
Increased by 5.06%
EPS This Year
2.59
from 2.61
Decreased by -0.83%
EPS Next Year
2.82
from 2.59
Increased by 8.88%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 55.8B | ||
| Avg | 55.2B | ||
| Low | 54.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.3% | ||
| Avg | 5.2% | ||
| Low | 4.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 2.59 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.8% | ||
| Low | - |